Oncology & Cancer

FDA approves iressa for EGFR metastatic lung cancer

(HealthDay)—Iressa (gefitinib) has been approved by the U.S. Food and Drug Administration to treat patients with metastatic non-small-cell lung cancer (NSCLC) with a specific genetic mutation (epidermal growth factor receptor ...

Diseases, Conditions, Syndromes

WHO calls for cholera vaccine production boost

The head of the World Health Organization on Thursday called for increased production of cholera vaccines, highlighting what he called a "critical shortage" around the globe.

Diseases, Conditions, Syndromes

UN Haiti cholera fund fails to draw pledges

A UN fund set up for Haiti's cholera victims is failing to draw support, with only two percent of the needed $400 million raised so far, according to a letter by UN Secretary-General Antonio Guterres.

page 2 from 2